5A7B

Structure of the p53 cancer Y220C bound to the stabilizing small molecule PhiKan5211

5A7B の概要

• エントリーDOI: 10.2210/pdb5a7b/pdb
• 分子名称: CELLULAR TUMOR ANTIGEN P53, ZINC ION, 2-[[4-(diethylamino)piperidin-1-yl]methyl]-6-ethynyl-4-(3-phenoxyprop-1-ynyl)phenol, ... (4 entities in total)
• 機能のキーワード: antitumor protein, cancer, tumor suppression, ethynyl, dna binding, cancer therapy, small molecule stabilizers, molecular chaperone
• 由来する生物種: HOMO SAPIENS (HUMAN)
• タンパク質・核酸の鎖数: 2
• 化学式量合計: 50025.55

構造登録者

Joerger, A.C. (登録日: 2015-07-03, 公開日: 2015-09-30, 最終更新日: 2024-01-10)

主引用文献

Wilcken, R.,Zimmermann, M.O.,Bauer, M.R.,Rutherford, T.J.,Fersht, A.R.,Joerger, A.C.,Boeckler, F.M.
Experimental and Theoretical Evaluation of the Ethynyl Moiety as a Halogen Bioisostere.
Acs Chem.Biol., 10:2725-, 2015

PubMed Abstract: Bioisosteric replacements are widely used in medicinal chemistry to improve physicochemical and ADME properties of molecules while retaining or improving affinity. Here, using the p53 cancer mutant Y220C as a test case, we investigate both computationally and experimentally whether an ethynyl moiety is a suitable bioisostere to replace iodine in ligands that form halogen bonds with the protein backbone. This bioisosteric transformation is synthetically feasible via Sonogashira cross-coupling. In our test case of a particularly strong halogen bond, replacement of the iodine with an ethynyl group resulted in a 13-fold affinity loss. High-resolution crystal structures of the two analogues in complex with the p53-Y220C mutant enabled us to correlate the different affinities with particular features of the binding site and subtle changes in ligand binding mode. In addition, using QM calculations and analyzing the PDB, we provide general guidelines for identifying cases where such a transformation is likely to improve ligand recognition.

PubMed: 26378745
DOI: 10.1021/ACSCHEMBIO.5B00515

実験手法

X-RAY DIFFRACTION (1.4 Å)